Advertisement

Topics

Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech

19:00 EDT 12 Jul 2018 | Pharmaceutical Technology

Dr. Reddy’s Laboratories has signed a distribution agreement with UCB to supply the latter’s epilepsy drug Briviact in India. As...
Read More...

The post Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech appeared first on Pharmaceutical Technology.

Original Article: Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech

NEXT ARTICLE

More From BioPortfolio on "Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...